SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000935836-23-000345
Filing Date
2023-03-24
Accepted
2023-03-24 16:49:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 ctibio13g.htm SC 13G 30313
  Complete submission text file 0000935836-23-000345.txt   31648
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 23760513
SIC: 2834 Pharmaceutical Preparations

Mailing Address 919 NW BOND STREET, SUITE 204 BEND OR 97703
Business Address
LYNCH TIMOTHY P (Filed by) CIK: 0001270925 (see all company filings)

Type: SC 13G